The atopic dermatitis medication dupilumab (Dupixent; Sanofi/Regeneron) may be a meaningful treatment option for patients with chronic lymphocytic leukemia (CLL) who experience persistent exaggerated responses to insect bites, according to a new report.
This article is intended to be general and/or educational in nature. Always consult your healthcare professional for help, diagnosis, guidance and treatment.
